ArticleAmerican journal of translational research2025
Clinical study on auricular point pressing beans combined with quetiapine in the treatment of alcohol-induced psychotic disorders.
Article in American journal of translational research, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
objectiveTo evaluate the clinical efficacy and safety of auricular point pressing beans combined with quetiapine in the treatment of alcohol-induced psychotic disorders.
methodsA total of 82 patients were enrolled and divided into a control group (38 cases) treated with quetiapine alone and an observation group (44 cases) treated with quetiapine combined with auricular point pressing beans. The treatment duration was four weeks.
resultsAfter the treatment, the observation group showed significantly better outcomes than the control group in terms of quality of life, positive and negative syndrome scale score, cognitive function, social functioning, and negative emotional state (all P < 0.05). The total effective rate in the observation group was 90.91%, significantly higher than that of the control group (73.68%, P < 0.05). Patient satisfaction (90.91%) and treatment compliance (88.64%) were also higher than those in the control group (73.68% and 71.05%, respectively; P < 0.05), while the incidence of adverse reactions was lower (P < 0.05). Univariate analysis identified age and duration of alcohol consumption as factors influencing treatment efficacy (both P < 0.05), which were further confirmed by multivariate logistic regression analysis.
conclusionAuricular point pressing beans combined with quetiapine can significantly improve clinical symptoms and quality of life in patients with alcohol-induced psychotic disorders, with good safety and tolerability. However, treatment efficacy tends to be lower in older patients and those with a longer history of alcohol consumption.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.